CRO in China – Leading the World with Rapid Growth
CR Medicon Expands Pharmacovigilance Management Capability in China With Oracle Argus
November 18, 2019
Innovative Chemical Drug Development in China
December 21, 2019
In recent years, the CRO (Contract Research Organization) industry in China has entered a “golden age” and is currently in a phrase of rapid growth and expansion. We published our China CRO market report, covering China’s current CRO market size and the growth projection. We also compared China’s CRO market with US and EU, other major CRO markets of the world. Please click here to download CR Medicon’s China CRO report.
Subscribe to our CRO newsletter to get updated with current development, events, and reports like this from our industry:
About Us
CR Medicon (https://en.crmedicon.com) provides innovative pharma and biotech companies with comprehensive clinical development services, including drug registration, medical affairs, clinical operations, data management & statistical analysis, and biological sample analysis. We are China’s most well-known clinical CRO partner, for both domestic and overseas companies. CR Medicon team consists more than 200 full-time employees with clinical sites in both USA and China. Contact us at +1 (732) 624-9052 or email biz@crmedicon.com.
